LMNA Gene (Lamin A/C): Structure, Function, and Associated Diseases

Comprehensive guide to the LMNA gene, its protein products, mutations, and clinical significance in laminopathies.

Gene Information Card

Symbol LMNA
Full Name Lamin A/C
Gene Type Protein coding
Chromosomal Location 1q22
NCBI Gene ID 4000 ncbi.nlm.nih.gov/gene/4000
Ensembl ID ENSG00000160789
UniProt ID P02545
OMIM ID 150330
HGNC ID 6636
Aliases CDCD1, CMD1A, CMT2B1, FPL, FPLD, HGPS, IDC, LDP1, LFP, LGMD1B, LMNC, LMNL1, PRO1

Description

The LMNA gene encodes lamin A and lamin C, two major components of the nuclear lamina, a filamentous meshwork underlying the inner nuclear membrane. These proteins provide structural support to the nucleus, regulate chromatin organization, and participate in DNA replication, transcription, and cell cycle control. Alternative splicing produces lamin A and lamin C isoforms. Mutations in LMNA cause a spectrum of diseases known as laminopathies, including Hutchinson-Gilford progeria syndrome, Emery-Dreifuss muscular dystrophy, dilated cardiomyopathy, and familial partial lipodystrophy.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hutchinson-Gilford progeria syndrome (HGPS) A de novo point mutation (c.1824C>T) activates a cryptic splice site, producing a truncated prelamin A (progerin) that is permanently farnesylated, disrupting the nuclear lamina and causing nuclear blebbing and premature aging. ClinVar; OMIM #176670
Emery-Dreifuss muscular dystrophy (EDMD) Missense and truncating mutations in LMNA disrupt nuclear lamina integrity, leading to muscle cell fragility and progressive weakness, often with cardiac conduction defects. ClinVar; OMIM #181350
Dilated cardiomyopathy 1A (CMD1A) Mutations in LMNA impair nuclear stability and gene regulation in cardiac myocytes, causing left ventricular dilation and systolic dysfunction, frequently with conduction system disease. ClinVar; OMIM #115200
Familial partial lipodystrophy type 2 (FPLD2) Specific missense mutations (e.g., R482W/Q) in the lamin A/C tail disrupt adipocyte differentiation and lipid metabolism, leading to selective loss of subcutaneous fat. ClinVar; OMIM #151660
Charcot-Marie-Tooth disease type 2B1 (CMT2B1) Homozygous LMNA mutations cause axonal neuropathy, likely due to impaired nuclear mechanics in peripheral nerves. ClinVar; OMIM #605588
Restrictive dermopathy Severe LMNA mutations cause lethal neonatal skin and skeletal abnormalities, due to defective nuclear envelope in fibroblasts. ClinVar; OMIM #275210

Expression Profile

Tissue Expression
Tissue nTPM level
Adipose tissue High High
Skeletal muscle High High
Heart High High
Skin Medium Medium
Liver Medium Medium
Brain Low Low
Cell Line Expression
Cell Line nTPM Notes
HeLa High Cervical carcinoma cell line
A549 High Lung carcinoma cell line
HUVEC Medium Endothelial cells
K562 Low Leukemia cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1824C>T (p.G608G) Point mutation (cryptic splice) De novo in HGPS Produces progerin, a permanently farnesylated lamin A variant causing nuclear abnormalities.
c.568C>T (p.R190W) Missense Rare in EDMD Disrupts lamin A/C dimerization, weakening nuclear lamina.
c.1444C>T (p.R482W) Missense Common in FPLD2 Alters lamin A/C interaction with chromatin, affecting adipocyte gene expression.
c.357A>G (p.K117E) Missense Rare in CMD1A Impairs nuclear stability in cardiac muscle, leading to dilated cardiomyopathy.
c.1622G>A (p.R541H) Missense Rare in CMT2B1 Causes axonal degeneration due to nuclear fragility in neurons.
Mutation functional classification

Loss of Function (LOF)

Loss-of-function mutations (e.g., frameshift, nonsense) reduce lamin A/C levels, leading to nuclear fragility and tissue-specific degeneration, as seen in some EDMD and CMD1A cases.

Gain of Function (GOF)

Gain-of-function mutations, such as the HGPS splice mutation, produce a toxic progerin protein that accumulates and disrupts nuclear function, causing premature aging.

Dominant Negative (DN)

Many missense mutations act in a dominant-negative manner, where the mutant protein interferes with the assembly of the nuclear lamina, compromising nuclear integrity and gene regulation.

Gene Ontology (GO)

• nuclear envelope organization • nuclear lamina
• structural constituent of nuclear pore • DNA replication
• chromatin organization • cell cycle
• apoptosis • mechanical stress response

Pathways

Nuclear Envelope Breakdown and Reformation
Laminopathies (Disease Pathway)
Aging and Progeria
Muscle Contraction and Cardiac Conduction

Protein Summary

The LMNA gene produces two major isoforms, lamin A and lamin C, via alternative splicing. Lamin A is synthesized as prelamin A, which undergoes farnesylation and proteolytic cleavage to mature lamin A. Both proteins form intermediate filaments that assemble into the nuclear lamina, providing structural support and anchoring chromatin. Lamin A/C interacts with numerous nuclear proteins, including emerin, LAP2, and chromatin modifiers, influencing gene expression and DNA repair. Post-translational modifications, such as phosphorylation, regulate lamina disassembly during mitosis. Mutations in LMNA disrupt these functions, leading to a range of tissue-specific diseases.

Related Products

Product name Cat.No. Species Gene ID
LMNA Knockout HEK293 Cell Line EDJ-KQ1983 Human 4000 Details Get a Quote
LMNA Knockout HCT 116 Cell Line EDJ-KQ21960 Human 4000 Details Get a Quote
LMNA Knockout HeLa Cell Line EDJ-KQ21961 Human 4000 Details Get a Quote
LMNA Knockout A-549 Cell Line EDJ-KQ20664 Human 4000 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: